The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis.

IF 2.1 4区 医学 Q3 GENETICS & HEREDITY
Jia-Lin Wu, Jun-Wei Chen, Ming-Sheng Huang, Xin-Yi Deng, Jia-Jun Deng, Tsz Yu Lau, Shi-Yu Cao, Hui-Ying Ran, Zai-Bo Jiang, Jun-Yang Luo
{"title":"The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis.","authors":"Jia-Lin Wu, Jun-Wei Chen, Ming-Sheng Huang, Xin-Yi Deng, Jia-Jun Deng, Tsz Yu Lau, Shi-Yu Cao, Hui-Ying Ran, Zai-Bo Jiang, Jun-Yang Luo","doi":"10.1186/s12920-024-01939-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is growing evidence for a relationship between gut microbiota and hepatic encephalopathy (HE). However, the causal nature of the relationship between gut microbiota and HE has not been thoroughly investigated.</p><p><strong>Method: </strong>This study utilized the large-scale genome-wide association studies (GWAS) summary statistics to evaluate the causal association between gut microbiota and HE risk. Specifically, two-sample Mendelian randomization (MR) approach was used to identify the causal microbial taxa for HE. The inverse variance weighted (IVW) method was used as the primary MR analysis. Sensitive analyses were performed to validate the robustness of the results.</p><p><strong>Results: </strong>The IVW method revealed that the genus Bifidobacterium (OR = 0.363, 95% CI: 0.139-0.943, P = 0.037), the family Bifidobacteriaceae (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039), and the order Bifidobacteriales (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039) were negatively associated with HE. However, no causal relationship was observed among them after the Bonferroni correction test. Neither heterogeneity nor horizontal pleiotropy was found in the sensitivity analysis.</p><p><strong>Conclusion: </strong>Our MR study demonstrated a potential causal association between Bifidobacterium, Bifidobacteriaceae, and Bifidobacteriales and HE. This finding may provide new therapeutic targets for patients at risk of HE in the future.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"17 1","pages":"216"},"PeriodicalIF":2.1000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334368/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Genomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12920-024-01939-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is growing evidence for a relationship between gut microbiota and hepatic encephalopathy (HE). However, the causal nature of the relationship between gut microbiota and HE has not been thoroughly investigated.

Method: This study utilized the large-scale genome-wide association studies (GWAS) summary statistics to evaluate the causal association between gut microbiota and HE risk. Specifically, two-sample Mendelian randomization (MR) approach was used to identify the causal microbial taxa for HE. The inverse variance weighted (IVW) method was used as the primary MR analysis. Sensitive analyses were performed to validate the robustness of the results.

Results: The IVW method revealed that the genus Bifidobacterium (OR = 0.363, 95% CI: 0.139-0.943, P = 0.037), the family Bifidobacteriaceae (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039), and the order Bifidobacteriales (OR = 0.359, 95% CI: 0.133-0.950, P = 0.039) were negatively associated with HE. However, no causal relationship was observed among them after the Bonferroni correction test. Neither heterogeneity nor horizontal pleiotropy was found in the sensitivity analysis.

Conclusion: Our MR study demonstrated a potential causal association between Bifidobacterium, Bifidobacteriaceae, and Bifidobacteriales and HE. This finding may provide new therapeutic targets for patients at risk of HE in the future.

肠道微生物群对肝性脑病的因果效应:泯灭随机分析。
背景:越来越多的证据表明,肠道微生物群与肝性脑病(HE)之间存在关系。然而,肠道微生物群与肝性脑病之间的因果关系尚未得到深入研究:本研究利用大规模全基因组关联研究(GWAS)的汇总统计来评估肠道微生物群与肝性脑病风险之间的因果关系。具体而言,该研究采用了双样本孟德尔随机化(MR)方法来确定与高血压有因果关系的微生物类群。反方差加权(IVW)法被用作主要的MR分析。为验证结果的稳健性,还进行了敏感性分析:IVW法显示,双歧杆菌属(OR = 0.363,95% CI:0.139-0.943,P = 0.037)、双歧杆菌科(OR = 0.359,95% CI:0.133-0.950,P = 0.039)和双歧杆菌目(OR = 0.359,95% CI:0.133-0.950,P = 0.039)与HE呈负相关。然而,经 Bonferroni 校正检验后,未发现它们之间存在因果关系。在敏感性分析中既未发现异质性,也未发现水平多向性:我们的磁共振研究表明,双歧杆菌、双歧杆菌科和双歧杆菌属与高血压之间存在潜在的因果关系。结论:我们的磁共振研究证明了双歧杆菌、双歧杆菌科和双歧杆菌与高血压之间的潜在因果关系,这一发现可能为今后高血压风险患者提供新的治疗目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medical Genomics
BMC Medical Genomics 医学-遗传学
CiteScore
3.90
自引率
0.00%
发文量
243
审稿时长
3.5 months
期刊介绍: BMC Medical Genomics is an open access journal publishing original peer-reviewed research articles in all aspects of functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信